Gilead Sciences Inc., 10% Owner at Arcus Biosciences, Inc. (RCUS), bought 5,650,000 shares at $39.00 ($220.3M) on 2021-01-31, disclosed to the SEC on 2021-02-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.